CareAcross has been sharing some of its findings and evidence with the scientific community, through conference proceedings and scientific journals.

The following reflect some of these references:


Analysis of evolution of patient reported side effects during treatment for advanced NSCLC (ESMO Annual Congress 2024)

SNF-CLIMEDIN: A prospective randomized trial of digital intervention in patients with advanced NSCLC—A HeCOG study (ASCO Annual Meeting 2024)

Engagement of patients with cancer with digital health platforms: An age-based analysis (ASCO Annual Meeting 2024)

Implementing geriatric assessment for dose optimization of CDK 4/6-inhibitors in older breast cancer patients (IMPORTANT trial): A pragmatic randomized-controlled trial (ESMO Breast Cancer Congress 2024)

SARC-Digital: An obServational, rAndomized, pRospeCtive study of the impact of digital health interventions on symptom and side-effect management in patients with metastatic sarcoma (ESMO Sarcomas and Rare Cancers 2024)

Clinical and molecular study with digital support of advanced non-small cell lung cancer patients: SNF-CLIMEDIN, a prospective randomized Hellenic Cooperative Oncology Group (HeCOG) study: Interim analysis (ESMO Annual Congress 2023)

Cancer therapy-associated thrombosis: A patient-reported outcomes (PROs) analysis (ASCO Annual Meeting 2023)

Real World Data Comparing Lung Cancer Side-Effects Between Past/Current Smokers And Never Smokers (IASLC World Conference on Lung Cancer 2022)

Differences In Toxicity Among Platinum-Based Combinations As Reported By Non-Small Cell Lung Cancer (NSCLC) Patients (IASLC World Conference on Lung Cancer 2022)

Comparative effectiveness of different interventions for cancer-related fatigue delivered digitally by online platforms (ASCO Annual Meeting 2022)

Usage and side effects of each common Aromatase Inhibitor in 5 large European countries: Real-world data analysis (ESMO Breast Cancer Congress 2022)

Real-World Evidence of comorbidities related to prognostic factors in European breast cancer patients (ESMO Breast Cancer Congress 2022)

Collecting quality of life information in a cohort of breast cancer survivors - Integrating electronic data collection into clinical practice (San Antonio Breast Cancer Symposium 2021)

European cancer patients’ perspectives on Immunotherapy (ESMO Annual Congress 2021)

Depression and anxiety in prostate cancer patients: Analysis of possible factors and correlations (ESMO Annual Congress 2021)

Analysis of patient-reported incidence of side-effects, and their improvement through online platforms (ESMO Annual Congress 2021)

Patient behaviors and attitudes towards lung cancer medication adherence (IASLC World Conference on Lung Cancer 2021)

Analysis of the support needs of lung cancer patients (IASLC World Conference on Lung Cancer 2021)

Immunotherapy in lung cancer: analysis of patients’ awareness and perceptions (IASLC World Conference on Lung Cancer 2021)

Analysis of Machine Learning Models Predicting Quality of Life for Cancer Patients (MEDES 2021)

Multifactorial analysis of cancer patients’ willingness for COVID-19 vaccination (ASCO Annual Meeting 2021)

Efficacy analysis of a remote symptom management platform (ASCO Annual Meeting 2021)

Artificial Intelligence Supporting CAncer Patients across Europe – the ASCAPE project for breast cancer patients (San Antonio Breast Cancer Symposium 2020)

ASCAPE - Artificial intelligence Supporting CAncer Patients across Europe (INISTA 2020)

CrowdHEALTH: An e-Health Big Data Driven Platform towards Public Health Policies (ICT4AWE 2020)

Breast cancer patients’ quality of life: Real-world data (ASCO Annual Meeting 2019)

CrowdHEALTH: Holistic Health Records and Big Data Analytics for Health Policy Making and Personalized Health (Studies in Health Technologies and Informatics 2017)